Icosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic use

Graphical Abstract Graphical Abstract Icosapent ethyl (IPE) for hypertriglyceridaemia—what are the pros and cons? In this graphical abstract, we highlight the pros and cons of IPE for the management of hypertriglyceridaemia, discuss the key results of three major clinical trials exploring the role o...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal 2024-02, Vol.45 (6), p.439-442
Main Authors: Gaba, Prakriti, Bhatt, Deepak L, Boden, William E
Format: Article
Language:English
Subjects:
Viewpoint
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Graphical Abstract Graphical Abstract Icosapent ethyl (IPE) for hypertriglyceridaemia—what are the pros and cons? In this graphical abstract, we highlight the pros and cons of IPE for the management of hypertriglyceridaemia, discuss the key results of three major clinical trials exploring the role of IPE or eicosapentaenoic acid on cardiovascular outcomes in subjects with hypertriglyceridaemia, and summarize practical considerations for clinicians considering IPE use in practice.
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehad668